BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 10981855)

  • 1. Role and relation of p70 S6 and extracellular signal-regulated kinases in the phenotypic changes of hypertrophy of cardiac myocytes.
    Ono Y; Ito H; Tamamori M; Nozato T; Adachi S; Abe S; Marumo F; Hiroe M
    Jpn Circ J; 2000 Sep; 64(9):695-700. PubMed ID: 10981855
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapamycin inhibits alpha 1-adrenergic receptor-stimulated cardiac myocyte hypertrophy but not activation of hypertrophy-associated genes. Evidence for involvement of p70 S6 kinase.
    Boluyt MO; Zheng JS; Younes A; Long X; O'Neill L; Silverman H; Lakatta EG; Crow MT
    Circ Res; 1997 Aug; 81(2):176-86. PubMed ID: 9242178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapamycin selectively inhibits angiotensin II-induced increase in protein synthesis in cardiac myocytes in vitro. Potential role of 70-kD S6 kinase in angiotensin II-induced cardiac hypertrophy.
    Sadoshima J; Izumo S
    Circ Res; 1995 Dec; 77(6):1040-52. PubMed ID: 7586215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specific role of the extracellular signal-regulated kinase pathway in angiotensin II-induced cardiac hypertrophy in vitro.
    Aoki H; Richmond M; Izumo S; Sadoshima J
    Biochem J; 2000 Apr; 347 Pt 1(Pt 1):275-84. PubMed ID: 10727428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significance of ERK cascade compared with JAK/STAT and PI3-K pathway in gp130-mediated cardiac hypertrophy.
    Kodama H; Fukuda K; Pan J; Sano M; Takahashi T; Kato T; Makino S; Manabe T; Murata M; Ogawa S
    Am J Physiol Heart Circ Physiol; 2000 Oct; 279(4):H1635-44. PubMed ID: 11009450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. U0126 reverses Ki-ras-mediated transformation by blocking both mitogen-activated protein kinase and p70 S6 kinase pathways.
    Fukazawa H; Uehara Y
    Cancer Res; 2000 Apr; 60(8):2104-7. PubMed ID: 10786668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ras/Erk signaling is essential for activation of protein synthesis by Gq protein-coupled receptor agonists in adult cardiomyocytes.
    Wang L; Proud CG
    Circ Res; 2002 Nov; 91(9):821-9. PubMed ID: 12411397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased protein kinase C activity in myotrophin-induced myocyte growth.
    Sil P; Kandaswamy V; Sen S
    Circ Res; 1998 Jun; 82(11):1173-88. PubMed ID: 9633917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bradykinin-stimulated protein synthesis by myocytes is dependent on the MAP kinase pathway and p70(S6K).
    Ritchie RH; Marsh JD; Schiebinger RJ
    Am J Physiol; 1999 Apr; 276(4):H1393-8. PubMed ID: 10199867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A farnesyltransferase inhibitor attenuates cardiac myocyte hypertrophy and gene expression.
    Calderone A; Abdelaziz N; Colombo F; Schreiber KL; Rindt H
    J Mol Cell Cardiol; 2000 Jun; 32(6):1127-40. PubMed ID: 10888263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NRG-1-induced cardiomyocyte hypertrophy. Role of PI-3-kinase, p70(S6K), and MEK-MAPK-RSK.
    Baliga RR; Pimental DR; Zhao YY; Simmons WW; Marchionni MA; Sawyer DB; Kelly RA
    Am J Physiol; 1999 Nov; 277(5):H2026-37. PubMed ID: 10564160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Focal adhesion kinase is involved in angiotensin II-mediated protein synthesis in cultured vascular smooth muscle cells.
    Govindarajan G; Eble DM; Lucchesi PA; Samarel AM
    Circ Res; 2000 Oct; 87(8):710-6. PubMed ID: 11029408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of the stress-activated protein kinases in endothelin-induced cardiomyocyte hypertrophy.
    Choukroun G; Hajjar R; Kyriakis JM; Bonventre JV; Rosenzweig A; Force T
    J Clin Invest; 1998 Oct; 102(7):1311-20. PubMed ID: 9769323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential regulation of phospholipase C-beta isozymes in cardiomyocyte hypertrophy.
    Schnabel P; Mies F; Nohr T; Geisler M; Böhm M
    Biochem Biophys Res Commun; 2000 Aug; 275(1):1-6. PubMed ID: 10944430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapamycin attenuates load-induced cardiac hypertrophy in mice.
    Shioi T; McMullen JR; Tarnavski O; Converso K; Sherwood MC; Manning WJ; Izumo S
    Circulation; 2003 Apr; 107(12):1664-70. PubMed ID: 12668503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IGF-1-stimulated protein synthesis in oligodendrocyte progenitors requires PI3K/mTOR/Akt and MEK/ERK pathways.
    Bibollet-Bahena O; Almazan G
    J Neurochem; 2009 Jun; 109(5):1440-51. PubMed ID: 19453943
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific role for the extracellular signal-regulated kinase pathway in angiotensin II- but not phenylephrine-induced cardiac hypertrophy in vitro.
    Ruf S; Piper M; Schlüter KD
    Pflugers Arch; 2002 Jan; 443(3):483-90. PubMed ID: 11810220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapamycin prevents thyroid hormone-induced cardiac hypertrophy.
    Kuzman JA; O'Connell TD; Gerdes AM
    Endocrinology; 2007 Jul; 148(7):3477-84. PubMed ID: 17395699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAP kinase- and Rho-dependent signals interact to regulate gene expression but not actin morphology in cardiac muscle cells.
    Thorburn J; Xu S; Thorburn A
    EMBO J; 1997 Apr; 16(8):1888-900. PubMed ID: 9155015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
    Sanada S; Kitakaze M; Node K; Takashima S; Ogai A; Asanuma H; Sakata Y; Asakura M; Ogita H; Liao Y; Fukushima T; Yamada J; Minamino T; Kuzuya T; Hori M
    Hypertension; 2001 Sep; 38(3):404-11. PubMed ID: 11566913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.